Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group-Reference-Cited by-同舟云学术

Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group

Published:2023-09-02 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Rovira Àlex^ORCID,Doniselli Fabio M.^ORCID,Auger Cristina^ORCID,Haider Lukas^ORCID,Hodel Jerome^ORCID,Severino Mariasavina^ORCID,Wattjes Mike P.^ORCID,van der Molen Aart J.^ORCID,Jasperse Bas^ORCID,Mallio Carlo A.^ORCID,Yousry Tarek^ORCID,Quattrocchi Carlo C.^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-023-10151-y.pdf

Reference91 articles.

1. Wattjes MP, Ciccarelli O, Reich DS et al (2021) 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 20:653–670

2. Rovira A, Auger C, Alonso J (2013) Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord 6:298–310

3. Gulani V, Calamante F, Shellock FG et al (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 16:564–570

4. Ognard J, Barrat JA, Cotton F et al (2021) A roadmap towards pollution prevention and sustainable development of Gadolinium. J Neuroradiol 48:409–411

5. Quattrocchi CC, Parillo M, Spani F et al (2023) Skin thickening of the scalp and high signal intensity of dentate nucleus in multiple sclerosis: association with linear versus macrocyclic gadolinium-based contrast agent administration. Invest Radiol 58:223–230. https://doi.org/10.1097/RLI.0000000000000929

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated transcriptomics of multiple sclerosis peripheral blood mononuclear cells identified COPG1, RPN1, and KDM3B as potential biomarkers;2024-08-09

2. Treatment Monitoring in Multiple Sclerosis — Efficacy and Safety;Neuroimaging Clinics of North America;2024-08

3. Typical and Emerging Diagnostic MRI Features in Multiple Sclerosis;Canadian Association of Radiologists Journal;2024-07-23

4. Medios de contraste basados en gadolinio de distribución extracelular;Radiología;2024-06

5. Amelioration of experimental autoimmune encephalomyelitis by gemfibrozil in mice via PPARβ/δ: implications for multiple sclerosis;Frontiers in Cellular Neuroscience;2024-05-21